Systemic Kras ablation disrupts myeloid cell homeostasis in adult mice
Proceedings of the National Academy of Sciences · 26.08.2025 · 122 (34)
DOI: 10.1073/pnas.2512404122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.08.2025. Verfasst von Elena Zamorano-Dominguez und 19 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Homeostasis, Myeloid Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CRIS Cancer Fundation, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spanish Ministry of Science and Innovation.
Abstract (Originalsprache)
The KRAS oncogene has been associated with many types of cancer, including pancreatic, lung, and colorectal. For decades, its gene products were thought to be undruggable. However, during the last decade, a large battery of KRAS inhibitors selective against specific mutations (KRAS G12C and KRAS G12D ), panKRAS inhibitors active against all KRAS isoforms, or even panRAS inhibitors, capable of inhibiting the three members of the RAS family, have been developed. In mice, the Kras locus is essential for embryonic development and can sustain adult homeostasis in the absence of Hras and Nras expression. Thus, we considered of interest to interrogate the role of the Kras locus in an experimental system to generate potentially relevant information regarding the use of panKRAS or panRAS inhibitors in the clinic. Here, we report that systemic ablation of Kras expression in adult mice does not induce significant changes in overall survival, body weight, glucose levels, metabolic profile, or heart function. In contrast, flow cytometry and histopathological analyses of organs such as blood, bone marrow, and spleen showed a significant increase of the myeloid lineage leading to myelomonocytic metaplasia. In this context, replacement of the KRAS isoforms by HRAS is sufficient to maintain adult homeostasis, suggesting that the unique properties of the Kras locus are primarily due to its pattern of expression rather than to the activity of its gene products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.
- Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.
- Global Pharma Strategy, F. Hoffmann-La Roche Ltd, Basil 4070, Switzerland.
- Molecular Oncology and Targeted Therapies Group, Centro Andaluz de Biología Molecular y Medicina Regenerativa, Consejo Superior de Investigaciones Científicas-Universidad de Sevilla-Universidad Pablo de Olavide, Seville…
- RAS Signalling and Lung Cancer Group, Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Salamanca 37007, Spain.
- Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid 28040, Spain.
ORCID-Profile: Eugenio Santos, Eduardo Caleiras, Carmen Guerra, Mariano Barbacid
Förderung
- CRIS Cancer Fundation
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
- Spanish Ministry of Science and Innovation
- Juan de la Cierva felloship
- Portuguese Foundation for Science and Technology
- INPhINIT fellowship from the "la Caixa" Foundation
- AECC fellowship
Zitieren
APA
Zamorano-Dominguez, E., Morales-Cacho, L., Barrero, R., Jiménez-Parrado, S., Dhawahir, A., Hernández-Porras, I., Simón-Carrasco, L., Barrambana, S., Sun, P., Galván-Del-Rey, A., Rosas-Perez, B., Liaki, V., Drosten, M., Musteanu, M., Virga, F., Santos, E., Mulero, F., Caleiras, E., Guerra, C., & Barbacid, M. (2025). Systemic Kras ablation disrupts myeloid cell homeostasis in adult mice. Proceedings of the National Academy of Sciences, 122(34). https://doi.org/10.1073/pnas.2512404122
Vancouver
Zamorano-Dominguez E, Morales-Cacho L, Barrero R, Jiménez-Parrado S, Dhawahir A, Hernández-Porras I, et al. Systemic Kras ablation disrupts myeloid cell homeostasis in adult mice. Proceedings of the National Academy of Sciences. 2025;122(34). doi:10.1073/pnas.2512404122
BibTeX
@article{ZamoranoDominguez2025,
author = {Zamorano-Dominguez, Elena and Morales-Cacho, Lucía and Barrero, Rebeca and Jiménez-Parrado, Silvia and Dhawahir, Alma and Hernández-Porras, Isabel and Simón-Carrasco, Lucía and Barrambana, Sara and Sun, Pian and Galván-Del-Rey, Ana and Rosas-Perez, Blanca and Liaki, Vasiliki and Drosten, Matthias and Musteanu, Mónica and Virga, Federico and Santos, Eugenio and Mulero, Francisca and Caleiras, Eduardo and Guerra, Carmen and Barbacid, Mariano},
title = {Systemic Kras ablation disrupts myeloid cell homeostasis in adult mice},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {34},
doi = {10.1073/pnas.2512404122}
}
EUVIMED